Literature DB >> 9393341

Benign symmetric lipomatosis associated with protease inhibitors.

R L Hengel, N B Watts, J L Lennox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9393341     DOI： 10.1016/s0140-6736(05)64011-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Metabolic Complications of HIV and AIDS.

Authors:  Alison Strawford; Marc K. Hellerstein
Journal:  Curr Infect Dis Rep       Date:  2001-04       Impact factor: 3.725

Review 2.  Indinavir: a review of its use in the management of HIV infection.

Authors:  G L Plosker; S Noble
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

3.  Metabolic effects of indinavir in healthy HIV-seronegative men.

Authors:  M A Noor; J C Lo; K Mulligan; J M Schwarz; R A Halvorsen; M Schambelan; C Grunfeld
Journal:  AIDS       Date:  2001-05-04       Impact factor: 4.177

Review 4.  Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?

Authors:  G M Behrens; M Stoll; R E Schmidt
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

5.  Alcohol consumption and lipodystrophy in HIV-infected adults with alcohol problems.

Authors:  Debbie M Cheng; Howard Libman; Carly Bridden; Richard Saitz; Jeffrey H Samet
Journal:  Alcohol       Date:  2009-02       Impact factor: 2.405

6.  Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study.

Authors:  Carl Grunfeld; David Rimland; Cynthia L Gibert; William G Powderly; Stephen Sidney; Michael G Shlipak; Peter Bacchetti; Rebecca Scherzer; Steven Haffner; Steven B Heymsfield
Journal:  J Acquir Immune Defic Syndr       Date:  2007-11-01       Impact factor: 3.731

Review 7.  Metabolic complications associated with HIV protease inhibitor therapy.

Authors:  David Nolan
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 8.  Autoimmunity and dysmetabolism of human acquired immunodeficiency syndrome.

Authors:  Yan-Mei Huang; Xue-Zhi Hong; Jia-Hua Xu; Jiang-Xi Luo; Han-You Mo; Hai-Lu Zhao
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

9.  Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor {gamma} and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy.

Authors:  Shashi Shrivastav; Tomoshige Kino; Tshaka Cunningham; Takamasa Ichijo; Ulrich Schubert; Peter Heinklein; George P Chrousos; Jeffrey B Kopp
Journal:  Mol Endocrinol       Date:  2007-10-11

10.  A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization.

Authors:  Fiona Young; Julia A Critchley; Lucy K Johnstone; Nigel C Unwin
Journal:  Global Health       Date:  2009-09-14       Impact factor: 4.185
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.